Inventor · disambiguated record
Douglas Michael Ackermann
Also filed as: ACKERMANN DOUGLAS M · ACKERMANN DOUGLAS MICHAEL · ACKERMANN JR DOUGLAS MICHAEL · ACKERMANN JR JR DOUGLAS MICHAEL
71 granted patents·39 pending applications·1,091 citations·filing 2010–2025
99Inventor score
Files withOCULEVE INC35TARSUS PHARMACEUTICALS INC18OYSTER POINT PHARMA INC14PRESIDIO MEDICAL INC13UNIV LELAND STANFORD JUNIOR6
Top patents by PatentIndex Score
110 records- 0198US11197847B2Isoxazoline parasiticide formulations and methods for treating blepharitisTARSUS PHARMACEUTICALS INC·Filed 2021·Granted Dec 14, 2021·11 cites·23 claims
- 0298US11027126B2Systems and methods for direct current nerve conduction blockPRESIDIO MEDICAL INC·Filed 2019·Granted Jun 8, 2021·13 cites·41 claims
- 0398US10238861B2Nasal stimulation devices and methods for treating dry eyeOCULEVE INC·Filed 2016·Granted Mar 26, 2019·28 cites·12 claims
- 0498US9737702B2Nasal stimulation devices and methodsOCULEVE INC·Filed 2016·Granted Aug 22, 2017·56 cites·20 claims
- 0597US11690826B2Methods for treating demodex blepharitis using lotilaner formulationsTARSUS PHARMACEUTICALS INC·Filed 2022·Granted Jul 4, 2023·6 cites·20 claims
- 0697US11690827B2Methods for treating ocular Demodex using lotilaner formulationsTARSUS PHARMACEUTICALS INC·Filed 2022·Granted Jul 4, 2023·6 cites·20 claims
- 0797US10252048B2Nasal stimulation for rhinitis, nasal congestion, and ocular allergiesOCULEVE INC·Filed 2017·Granted Apr 9, 2019·38 cites·18 claims
- 0897US10155108B2Nasal stimulation devices and methodsOCULEVE INC·Filed 2014·Granted Dec 18, 2018·36 cites·28 claims
- 0997US9440065B2Nasal stimulation devices and methodsOCULEVE INC·Filed 2014·Granted Sep 13, 2016·66 cites·27 claims
- 1097US8996137B2Nasal stimulation devices and methodsOCULEVE INC·Filed 2014·Granted Mar 31, 2015·109 cites·23 claims
- 1196US12364685B2Isoxazoline parasiticide formulationsTARSUS PHARMACEUTICALS INC·Filed 2024·Granted Jul 22, 2025·1 cites·32 claims
- 1296US12213964B2Isoxazoline parasiticide formulationsTARSUS PHARMACEUTICALS INC·Filed 2023·Granted Feb 4, 2025·2 cites·21 claims
- 1396US12171750B2Isoxazoline parasiticide formulations and methods for treating blepharitisTARSUS PHARMACEUTICALS INC·Filed 2023·Granted Dec 24, 2024·2 cites·16 claims
- 1496US11911380B2Compositions and use of varenicline for treating dry eyeOYSTER POINT PHARMA INC·Filed 2023·Granted Feb 27, 2024·2 cites·30 claims
- 1596US11903941B2Compositions and use of varenicline for treating dry eyeOYSTER POINT PHARMA INC·Filed 2021·Granted Feb 20, 2024·2 cites·24 claims
- 1696US11903943B2Compositions and use of varenicline for treating dry eyeOYSTER POINT PHARMA INC·Filed 2023·Granted Feb 20, 2024·2 cites·30 claims
- 1796US11752137B2Ophthalmic compositions for treating ocular Demodex using lotilaner formulationsTARSUS PHARMACEUTICALS INC·Filed 2022·Granted Sep 12, 2023·4 cites·20 claims
- 1896US11224598B2Methods of increasing lacrimal proteinsOYSTER POINT PHARMA INC·Filed 2019·Granted Jan 18, 2022·6 cites·19 claims
- 1996US9764150B2Contact lens for increasing tear productionOCULEVE INC·Filed 2015·Granted Sep 19, 2017·37 cites·21 claims
- 2095US11903942B2Compositions and use of varenicline for treating dry eyeOYSTER POINT PHARMA INC·Filed 2023·Granted Feb 20, 2024·1 cites·30 claims
- 2195US10835517B2Methods for treating ocular demodex using isoxazoline parasiticide formulationsTARSUS PHARMACEUTICALS INC·Filed 2018·Granted Nov 17, 2020·12 cites·28 claims
- 2295US10143846B2Systems and methods for treatment of dry eyeUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Dec 4, 2018·19 cites·17 claims
- 2395US9498621B2Separated-interface nerve electrodeUNIV CASE WESTERN RESERVE·Filed 2015·Granted Nov 22, 2016·27 cites·12 claims
- 2495US9149643B2System for communicating with implantable medical devices using a bridge deviceBOSTON SCIENT NEUROMODULATION·Filed 2015·Granted Oct 6, 2015·17 cites·25 claims
- 2594US12268865B2Current bias as a control mechanism for electrode operationPRESIDIO MEDICAL INC·Filed 2020·Granted Apr 8, 2025·3 cites·20 claims
- 2694US10456396B2Dry eye treatmentsOYSTER POINT PHARMA INC·Filed 2017·Granted Oct 29, 2019·9 cites·100 claims
- 2794US9597284B2Dry eye treatmentsOYSTER POINT PHARMA INC·Filed 2015·Granted Mar 21, 2017·11 cites·15 claims
- 2894US9532944B2Methods of improving ocular discomfortOYSTER POINT PHARMA INC·Filed 2015·Granted Jan 3, 2017·12 cites·15 claims
- 2994US9504644B2Methods of increasing tear productionOYSTER POINT PHARMA INC·Filed 2015·Granted Nov 29, 2016·11 cites·15 claims
- 3094US9504645B2Pharmaceutical formulations for treating ocular conditionsOYSTER POINT PHARMA INC·Filed 2015·Granted Nov 29, 2016·10 cites·13 claims
- 3194US9265956B2Devices and methods for treating dry eye in animalsOCULEVE INC·Filed 2014·Granted Feb 23, 2016·62 cites·7 claims
- 3294US9095723B2Systems and methods for treatment of dry eyeUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Aug 4, 2015·38 cites·12 claims
- 3394US9008800B2Separated-interface nerve electrodeACKERMANN JR DOUGLAS MICHAEL·Filed 2010·Granted Apr 14, 2015·43 cites·9 claims
- 3494US8918181B2Systems and methods for treatment of dry eyeACKERMANN DOUGLAS MICHAEL·Filed 2011·Granted Dec 23, 2014·52 cites·78 claims
- 3593US11918803B2Systems and methods for direct current nerve conduction blockPRESIDIO MEDICAL INC·Filed 2021·Granted Mar 5, 2024·2 cites·21 claims
- 3693US11730964B2Pulse generation and stimulation engine systemsPRESIDIO MEDICAL INC·Filed 2020·Granted Aug 22, 2023·4 cites·21 claims
- 3793US10272240B2Systems and methods for direct current nerve conduction blockPRESIDIO MEDICAL INC·Filed 2018·Granted Apr 30, 2019·15 cites·21 claims
- 3892US9821159B2Stimulation devices and methodsACKERMANN DOUGLAS MICHAEL·Filed 2012·Granted Nov 21, 2017·50 cites·12 claims
- 3991US9717627B2Implant delivery devices, systems, and methodsOCULEVE INC·Filed 2014·Granted Aug 1, 2017·33 cites·13 claims
- 4091US8983615B2System for communication with implantable medical devices using a bridge deviceTAHMASIAN SAMUEL·Filed 2012·Granted Mar 17, 2015·48 cites·34 claims
- 4191US2025127762A1Isoxazoline parasiticide formulations and methods for treating blepharitisTARSUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4290US10940310B2Nasal stimulation for rhinitis, nasal congestion, and ocular allergiesOCULEVE INC·Filed 2019·Granted Mar 9, 2021·9 cites·25 claims
- 4390US10709707B2Methods of treating ocular conditionsOYSTER POINT PHARMA INC·Filed 2017·Granted Jul 14, 2020·7 cites·72 claims
- 4490US10207108B2Implantable nasal stimulator systems and methodsOCULEVE INC·Filed 2015·Granted Feb 19, 2019·17 cites·23 claims
- 4590US2024173318A1Dry eye treatmentsOYSTER POINT PHARMA INC·Filed 2024·Application pending·0 cites
- 4689USD826420SNasal stimulator deviceOCULEVE INC·Filed 2016·Granted Aug 21, 2018·29 cites·1 claims
- 4789US9364661B2Adjustable nerve electrodeUNIV CASE WESTERN RESERVE·Filed 2014·Granted Jun 14, 2016·26 cites·15 claims
- 4888US10039917B2Adjustable nerve electrodeUNIV CASE WESTERN RESERVE·Filed 2016·Granted Aug 7, 2018·9 cites·9 claims
- 4988US2025312317A1Isoxazoline parasiticide formulations and methods for treating blepharitisTARSUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 5088US2025121197A1Systems and methods for treatment of dry eyeUNIV LELAND STANFORD JUNIOR·Filed 2024·Application pending·0 cites
Showing the top 50 of 110 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Douglas Michael Ackermann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →